Electronic supplementary material Additional file 1: Figure S1: LMP1 promoted the interaction of phosphorylated EGFR and phosphorylated STAT3. Two mg of protein from cell lysates were immunoprecipitated with an anti-phosphorylated EGFR antibody (p-EGFR) and analyzed by Western blotting with a phosphorylated STAT3 (p-STAT3)
and p-EGFR antibodies. Negative controls selleck products included immunoprecipitation with an unrelated antibody (IgG). (PPT 4 MB) References 1. Raab-Traub N: Epstein–Barr virus transforming proteins: biologic properties and contribution to oncogenesis. In DNA tumor viruses. Edited by: Damania B, Pipas JM. New York, NY: Springer; 2009:259–284.CrossRef 2. Strong MJ, Xu G, Coco J, Baribault C, Vinay DS, Lacey MR, Strong AL, Lehman TA, Seddon MB, Lin Z, et al.: Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog 2013,9(5):e1003341.PubMedCrossRef 3. van Beek J, zur Hausen A, Klein Kranenbarg E, van de Velde CJ, Middeldorp JM, van den Brule AJ, Meijer CJ, Bloemena E: EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. J Clin Oncol 2004,22(4):664–670.PubMedCrossRef Niraparib 4. Kijima Y, Ishigami S,
Hokita S, Koriyama C, Akiba S, Eizuru Y, Aikou T: The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Cancer Lett 2003,200(1):33–40.PubMedCrossRef 5. Sasagawa T, Shimakage M, Nakamura M, Sakaike J, Ishikawa H, Inoue
M: Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer: a comparative study with human papillomavirus (HPV) infection. Hum Pathol 2000,31(3):318–326.PubMedCrossRef 6. Schmauz R, Okong P, de Villiers EM, Dennin R, Brade L, Lwanga SK, Owor R: Multiple infections in cases of cervical cancer from a high-incidence area in tropical Low-density-lipoprotein receptor kinase Africa. Int J Cancer 1989,43(5):805–809.PubMedCrossRef 7. Yang YY, Koh LW, Tsai JH, Tsai CH, Wong EF, Lin SJ, Yang CC: Correlation of viral factors with cervical cancer in Taiwan. J Microbiol Immunol selleck inhibitor Infect 2004,37(5):282–287.PubMed 8. Awerkiew S, Bollschweiler E, Metzger R, Schneider PM, Holscher AH, Pfister H: Esophageal cancer in Germany is associated with Epstein-Barr-virus but not with papillomaviruses. Med Microbiol Immunol 2003,192(3):137–140.PubMedCrossRef 9. Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS: Human papillomavirus and Epstein Barr virus in prostate cancer: koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate 2013,73(3):236–241.PubMedCrossRef 10. Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, et al.